Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Financings
Financings
| Raise | Date |
|---|---|
| Private placement of series B-2 Convertible Preferred Stock and common warrants Announced: US$11M · Warrants at US$1.03 for 36 months · E.F. Hutton & Co. Dealers: E.F. Hutton & Co. (lead) | Apr 30, 2026 |
| Private placement of pre-funded warrant Announced: about US$2.5M · US$4 a share · WestPark Capital, Inc. Dealers: WestPark Capital, Inc. (lead) Use of proceeds: Marketing, general corporate purposes and working capital | Nov 3, 2025 |
| Private placement of shares of common stock (or pre-funded warrants) Closed: US$4.25M raised · US$3.6 a share · WestPark Capital, Inc. Dealers: WestPark Capital, Inc. (lead) Use of proceeds: Potential acquisitions, marketing and other general corporate purposes | Jun 24, 2025 |
| Public offering of shares of common stock (or pre-funded warrants) Closed: US$5.75M raised · US$0.3 a share · WestPark Capital, Inc. Dealers: WestPark Capital, Inc. (lead) Use of proceeds: Phase II clinical trial for lead product candidate, marketing and advertising, working capital and general corporate purposes | Mar 13, 2025 |